Resistance to apoptosis is increased during metastatic dissemination of colon cancer

[1]  D. Henson,et al.  Biomarkers for early detection of colon cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[2]  G. Peters,et al.  5-Fluorouracil induced Fas upregulation associated with apoptosis in liver metastases of colorectal cancer patients. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  M. Priault,et al.  The substitution of the C‐terminus of bax by that of bcl‐xL does not affect its subcellular localization but abrogates its pro‐apoptotic properties , 2000, FEBS letters.

[4]  Y. Lazebnik,et al.  Evaluation of Apaf-1 and procaspases-2, -3, -7, -8, and -9 as potential prognostic markers in acute leukemia. , 2000, Blood.

[5]  G. Peters,et al.  Downstream molecular determinants of response to 5-fluorouracil and antifolate thymidylate synthase inhibitors. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

[6]  M. Hull,et al.  The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: evidence of different mechanisms of action. , 2000, European journal of cancer.

[7]  J. Yokota,et al.  Tumor progression and metastasis. , 2000, Carcinogenesis.

[8]  I. Thorup,et al.  Review of colorectal cancer and its metastases in rodent models: comparative aspects with those in humans. , 2000, Comparative medicine.

[9]  R. Kucherlapati,et al.  Short-chain fatty acid metabolism, apoptosis, and Apc-initiated tumorigenesis in the mouse gastrointestinal mucosa. , 1999, Cancer research.

[10]  M. Grégoire,et al.  Antigen-presenting cells that phagocytose apoptotic tumor-derived cells are potent tumor vaccines. , 1999, Cancer research.

[11]  C. Vasselon,et al.  Expression of apoptosis-controlling proteins in acute leukemia cells. , 1999, Leukemia & lymphoma.

[12]  B. Dörken,et al.  Analysis of the p53/BAX pathway in colorectal cancer: low BAX is a negative prognostic factor in patients with resected liver metastases. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  F. Maley,et al.  Regulation of p53 expression by thymidylate synthase. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[14]  L. Butler,et al.  Deregulation of apoptosis in colorectal carcinoma: theoretical and therapeutic implications. , 1999, The Australian and New Zealand journal of surgery.

[15]  L. Oliver,et al.  Induction of a Caspase-3-like Activity by Calcium in Normal Cytosolic Extracts Triggers Nuclear Apoptosis in a Cell-free System* , 1998, The Journal of Biological Chemistry.

[16]  M. Heymann,et al.  5‐fluorouracil‐resistant colonic tumors are highly responsive to sodium butyrate/interleukin‐2 bitherapy in rats , 1997, International journal of cancer.

[17]  F. Bornet,et al.  Short-chain fructo-oligosaccharides reduce the occurrence of colon tumors and develop gut-associated lymphoid tissue in Min mice. , 1997, Cancer research.

[18]  J. Harb,et al.  Induction of fibroblast gelatinase B expression by direct contact with cell lines derived from primary tumor but not from metastases. , 1996, Cancer research.

[19]  K. Kinzler,et al.  Lessons from Hereditary Colorectal Cancer , 1996, Cell.

[20]  S. Lowe,et al.  Cancer therapy and p53. , 1995, Current opinion in oncology.

[21]  D. Alberts,et al.  Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. , 1995, Cancer research.

[22]  Muneesh Tewari,et al.  Yama/CPP32β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase , 1995, Cell.

[23]  P. Pasricha,et al.  Inhibition of apoptosis during development of colorectal cancer. , 1995, Cancer research.

[24]  D. Hicks,et al.  Apoptosis in colorectal tumour cells: Induction by the short chain fatty acids butyrate, propionate and acetate and by the bile salt deoxycholate , 1995, International journal of cancer.

[25]  A. Manning,et al.  Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53‐independent pathway: Implications for the possible role of dietary fibre in the prevention of large‐bowel cancer , 1993, International journal of cancer.

[26]  I. Taylor.  Chemotherapy, radiotherapy, and immunotherapy of colorectal neoplasia , 1993 .

[27]  A. Barbat,et al.  Increased growth adaptability to 5‐fluorouracil and methotrexate of HT‐29 sub‐populations selected for their commitment to differentiation , 1991, International journal of cancer.

[28]  A. Altendorf-Hofmann,et al.  Hepatic metastases from colorectal carcinoma: Impact of surgical resection on the natural history , 1990, The British journal of surgery.

[29]  J. Laurie,et al.  Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  Christopher W. Wong,et al.  Apoptosis: an early event in metastatic inefficiency. , 2001, Cancer research.

[31]  M. Mandal,et al.  Butyric acid induces apoptosis by up-regulating Bax expression via stimulation of the c-Jun N-terminal kinase/activation protein-1 pathway in human colon cancer cells. , 2001, Gastroenterology.

[32]  J C Reed,et al.  Dysregulation of apoptosis in cancer. , 1998, The cancer journal from Scientific American.

[33]  U. Schumacher,et al.  The action of 5-fluorouracil on human HT29 colon cancer cells grown in SCID mice: mitosis, apoptosis and cell differentiation. , 1997, British Journal of Cancer.

[34]  Z. Oltvai,et al.  Bcl-2 gene family and the regulation of programmed cell death. , 1994, Cold Spring Harbor symposia on quantitative biology.

[35]  J. Douillard,et al.  Karyotypic and phenotypic variations between cell lines established from a primary colorectal tumour and two corresponding metastases from one patient. , 1993, Invasion & metastasis.